[Therapy of peripheral oculomotor paralysis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D001763:Blepharoptosis / Q000628:therapy; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004172:Diplopia / Q000209:etiology; D004576:Electromyography; D004585:Electrooculography; D004700:Endocrine System Diseases / Q000150:complications / Q000628:therapy; D005094:Exophthalmos / Q000628:therapy; D005128:Eye Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009135:Muscular Diseases / Q000209:etiology; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000628:therapy; D009220:Myositis / Q000628:therapy; D009224:Myotonia Congenita / Q000628:therapy; D009468:Neuromuscular Diseases / Q000628:therapy; D009801:Oculomotor Muscles / Q000601:surgery; D009886:Ophthalmoplegia / Q000601:surgery / Q000628:therapy*; D009988:Orthoptics; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D013285:Strabismus / Q000150:complications / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D013956:Antithyroid Agents; D002800:Cholinesterase Inhibitors; D011729:Pyridostigmine Bromide
Therapie der peripheren Augenmuskellähmungen.